VIP and familial pancreatic carcinoma: Furthermore, VIP antagonist increased activated CD8+ T cell in tumor-bearing mice engrafted with pancreatic cancer cell lines23 However, the effect of VIP antagonist on macrophage polarization and function in tumor models remains unknown.